Maria L. Thompson, Eric J. Kunkel, and Rolf O. Ehrhardt
Successful commercial and clinical application of stem cells requires robust and practical cryopreservation protocols. Stem cells, particularly human embryonic stem cells and induced pluripotent stem cells, are notoriously sensitive to cryopreservation, requiring specialized protocols to maintain optimal cell viability.
Among the top 6 globally administered vaccines, up to 36% of their effective shelf-life is lost due to poor cold chain management. No physician wants to be in the position of administering a vaccine that may have been compromised by exposure to the wrong temperature.
World Adopt Summit: Interview with MedCision CEO, Rolf Ehrhardt
Rolf Ehrhardt, MD, PhD
Standardization and automation are going to be key in order for these therapies to move into a global market and ensure that patient demand can be met. Too often we see pharmaceutical developers put an enormous effort into ensuring efficacy and safety of their product.